CLDX
NASDAQ · Biotechnology
Celldex Therapeutics Inc
$30.90
+0.87 (+2.90%)
Open$30.26
Previous Close$30.03
Day High$31.85
Day Low$29.95
52W High$30.50
52W Low$14.40
Volume—
Avg Volume680.2K
Market Cap1.56B
P/E Ratio—
EPS$-3.38
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
+68.5% upside
Current
$30.90
$30.90
Target
$52.08
$52.08
$39.61
$52.08 avg
$81.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 7.41M | 6.46M | 613.37M |
| Net Income | -166,653,055 | -130,742,459 | -4,777,656 |
| Profit Margin | -2,248.8% | -2,136.3% | -0.8% |
| EBITDA | -202,587,301 | -167,763,193 | -9,452,277 |
| Free Cash Flow | — | — | -4,482,621 |
| Rev Growth | +14.7% | +14.7% | +23.6% |
| Debt/Equity | — | — | 0.95 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |